Davenport & CO LLC Elanco Animal Health Inc Transaction History
Davenport & CO LLC
- $16.8 Billion
- Q3 2024
A detailed history of Davenport & CO LLC transactions in Elanco Animal Health Inc stock. As of the latest transaction made, Davenport & CO LLC holds 10,955 shares of ELAN stock, worth $146,358. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,955
Previous 11,255
2.67%
Holding current value
$146,358
Previous $162,000
1.23%
% of portfolio
0.0%
Previous 0.0%
Shares
18 transactions
Others Institutions Holding ELAN
# of Institutions
437Shares Held
473MCall Options Held
4.62MPut Options Held
753K-
Dodge & Cox San Francisco, CA83.3MShares$1.11 Billion0.74% of portfolio
-
Primecap Management CO Pasadena, CA52.6MShares$702 Million0.58% of portfolio
-
Vanguard Group Inc Valley Forge, PA48.9MShares$654 Million0.01% of portfolio
-
Black Rock Inc. New York, NY23.3MShares$311 Million0.01% of portfolio
-
Black Creek Investment Management Inc. Toronto, A621.3MShares$285 Million11.09% of portfolio
About Elanco Animal Health Inc
- Ticker ELAN
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 474,113,984
- Market Cap $6.33B
- Description
- Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet...